<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04305262</url>
  </required_header>
  <id_info>
    <org_study_id>H-19086056</org_study_id>
    <nct_id>NCT04305262</nct_id>
  </id_info>
  <brief_title>Continuous Monitoring of Vital Parameters for Early Detection of Clinical Deterioration in Hospitalized Patients - A Pilot Study</brief_title>
  <acronym>WARD</acronym>
  <official_title>Continuous Monitoring of Vital Parameters for Early Detection of Clinical Deterioration in Hospitalized Patients - a Part of the Wireless Assessment of Respiratory and Circulatory Distress (WARD) Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Bispebjerg and Frederiksberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Technical University of Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Bispebjerg and Frederiksberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For patients admitted to the medical ward, it is often difficult to predict if their clinical
      condition will deteriorate, however subtle changes in vital signs are usually present 8 to 24
      hours before a life-threatening event such as respiratory failure leading to ICU admission,
      or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed,
      misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital
      parameter monitoring systems offer a unique possibility to identify clinical deterioration
      before patients condition progress beyond the point-of-no-return, where adverse events are
      inevitable. The WARD project aims to determine the correlation between cardiopulmonary micro
      events and clinical adverse events during the first four days after hospital admission.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 25, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serious desaturation</measure>
    <time_frame>more than 10 minutes, within the first four days of acute admission</time_frame>
    <description>SpO2 &lt;85% in 10 consecutive minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>desaturation</measure>
    <time_frame>more than 60 minutes, within the first four days of acute admission</time_frame>
    <description>SpO2 &lt;92% in 60 consecutive minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tachycardia</measure>
    <time_frame>one minute within the first four days of admission</time_frame>
    <description>Heartrate &gt;130/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bradycardia</measure>
    <time_frame>one minute within the first four days of admission</time_frame>
    <description>heartrate &gt;41/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tachypnea</measure>
    <time_frame>one minute within the first four days of admission</time_frame>
    <description>Respiration rate &gt;24/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bradypnea</measure>
    <time_frame>one minute within the first four days of admission</time_frame>
    <description>Respiration rate &lt;9/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypotension</measure>
    <time_frame>one measurement within the first four days of admission</time_frame>
    <description>Systolic blood pressure &lt;90 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypertension</measure>
    <time_frame>one measurement wihtin the first four days of admission</time_frame>
    <description>systolic blood pressure &gt;219 mmHg</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Continuous Wireless Vital Parameter Monitoring</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wireless continuous vital parameter monitoring</intervention_name>
    <description>The patients included in this study will have continuous, wireless monitoring of vital parameters during the first four days of acute admission</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patients at general medical wards, that are in high-risk of deterioration
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults &gt;18 years

          -  Acute hospitalization or discharge from Intensive Care Unit (ICU) after an admission
             of at least 24 hours.

          -  Early Warning Score (EWS) ≥4 at least once from admission and until inclusion

          -  One of the following tentative diagnoses as the primary reason for admission:
             Pneumonia, Dyspnea, Acute myocardial infarction, heartfailure or sepsis

          -  Inclusion conversation possible within 12 hours of admission or discharge from ICU

        Exclusion Criteria:

          -  Patients that cannot cooperate

          -  Patients that cannot give informed consent

          -  Patients with EWS≥4 that is not of presumed physical origin

          -  Patients with allergies to plaster or silicone

          -  Patients with pacemaker or ICD

          -  Patients with treatment limitations (no resuscitation or no admission to ICU)

          -  Patients with expected discharge within 24 hours

          -  Patients that have been included in the WARD-COPD study (H-18026653)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Meyhoff, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katja Grønbæk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Meyhoff, MD, PhD</last_name>
    <phone>004524910542</phone>
    <email>christian.sylvest.meyhoff@regionh.dk</email>
  </overall_contact>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 9, 2020</study_first_submitted>
  <study_first_submitted_qc>March 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2020</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Bispebjerg and Frederiksberg</investigator_affiliation>
    <investigator_full_name>Katja Kjær Grønbæk</investigator_full_name>
    <investigator_title>MD, PhD-student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clinical Deterioration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

